HALO
Halozyme Therapeutics, Inc. · Healthcare
SVP and Chief Technical Officer Michael J. Labarre sold $1.1M of Halozyme Therapeutics, Inc.
Sold$1,100,023
$55.00Price
20,000Shares
−11%Stake
What HALO did after the filing
- The stock from Wed, Jul 24 close, $55.15
- +10.7%
- S&P 500, same days
- +1.5%
Measured over 30 trading days, to the Sep 5 close.
Traded Tue, Jul 23. Filed Wed, Jul 24, 1:48 PM ET, during the session. Returns use the Jul 24 close and the Sep 5 close. Not investment advice.